| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| FIBROGEN INC | Chief Financial Officer | Common Stock | 4,489 | $37,797 | $8.42 | 06 Dec 2025 | Direct |
| KYNTRA BIO, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 26,000 | 03 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KYNB | KYNTRA BIO, INC. | 03 Feb 2026 | 1 | $0 | 4 | Chief Financial Officer | 05 Feb 2026, 21:06 |
| FGEN | FIBROGEN INC | 06 Dec 2025 | 1 | -$438 | 4 | Chief Financial Officer | 09 Dec 2025, 16:11 |
| FGEN | FIBROGEN INC | 06 Jun 2025 | 2 | -$1,041 | 4 | Chief Financial Officer | 09 Sep 2025, 19:26 |
| FGEN | FIBROGEN INC | 06 Mar 2025 | 1 | -$907 | 4 | Chief Financial Officer | 07 Mar 2025, 19:01 |
| FGEN | FIBROGEN INC | 09 Jan 2025 | 1 | $0 | 4 | Chief Financial Officer | 10 Jan 2025, 18:16 |
| FGEN | FIBROGEN INC | 16 Dec 2024 | 0 | $0 | 3 | Chief Financial Officer | 18 Dec 2024, 17:01 |